About Dr. Alexander
Dr. Richard Alexander — Chief Surgical Officer at Rutgers Cancer Institute in New Jersey — is both a skilled surgeon and a passionate researcher.
He chose to specialize in peritoneal mesothelioma after discovering how pessimistic other doctors were about the disease. He wants to help patients to live longer and have a better quality of life, and he believes that one day a cure will be found.
Dr. Alexander has worked tirelessly to find a cure, and he is known internationally for his efforts.
Over the course of his career, he has discovered the link between specific proteins and mesothelioma. This discovery is paving the way for new kinds of treatments that will help stop mesothelioma tumors from growing.
He is also dedicated to improving the effectiveness of the current standard surgery for peritoneal mesothelioma — a combination of cytoreduction surgery and heated chemotherapy drugs applied directly to the abdominal cavity.
On top of his clinical trials focusing on proteins, he has written more than 250 journal articles on cancer research. He has also spent time lecturing on the topic of peritoneal mesothelioma in the United States and abroad.
After Dr. Alexander received his medical degree from Georgetown University School of Medicine where he served as a medical officer in the U.S. Navy for 8 years.
During his time of service, he worked out of the Walter Reed Military Medical Center in Bethesda while he finished his general surgery residency. He then spent time working as a medical officer aboard the USS Mt. Whitney and the USS Midway.
After his military service, he began working at the Memorial Sloan-Kettering Cancer Centre in New York where he completed his fellowship in surgical oncology. He then returned to military service for another 4 years, serving as Commander at the Walter Reed Medical Center.
Once his second stint in the military was over, he went to work for the Surgery Branch of the National Cancer Institute (NCI).
During his 16 years at the NCI, he held several notable positions. He was the chief of the surgical metabolism area, chairman of the gastrointestinal malignancies section, and deputy director of the Center for Cancer Research.
While working at the NCI, he was also a professor and associate chair of clinical research for the University of Maryland School of Medicine’s Department of Surgery.
He instructed teams researching proteins linked to mesothelioma. His teams created internationally recognized research programs for cancer patients.
In 2017, he began working as the Chief Surgical Officer of the Rutgers Cancer Institute in New Jersey.